44.

25 In peptic ulcer, antacids are now primarily used for:

A. Prompt pain relief
B. Ulcer healing
C. Preventing ulcer relapse
D. Control of bleeding from the ulcer (p. 596)
44.26 Sucralfate promotes healing of duodenal ulcer by:
A. Enhancing gastric mucus and bicarbonate
secretion
B. Coating the ulcer and preventing the action
of acid-pepsin on ulcer base
C. Promoting regeneration of mucosa
D. Both "A" and B are correct
0 0
(p. 596)

44.27 Antacids administered concurrently reduce efficacy

of the following antipeptic ulcer drug:
A. Clmetldlne
B. Colloidal bismuth
C. Sucralfate
D. Pirenzeplne (p. 596-597)

44.28 The following antiulcerdrug does not act by reducing

the secretion of or neutralizing gastric acid:
A. Magaldrate
B. Sucralfate
C. Mlsoprostol
D. Omeprazole (p. 596)
44.29 The most important drawback of sucralfate in the
treatment of duodenal ulcer is :
A. Low ulcer healing efficacy
B. Poor relief of ulcer pain
C. High Incidence of side effects
D. Need for taking a big tablet four times a day
(p. 596)

144 . 25A 44 . 26B 44 . 27C 44 . 28B 44 . 29D I